ACR适宜性标准:I期乳腺癌无症状女性的初始分期检查及局部复发与远处转移监测
针对新诊断I期乳腺癌无症状女性,ACR适宜性标准基于文献分析及改良Delphi共识方法指出,无证据支持初始分期检查以排除转移可改善生存或生活质量;美国临床肿瘤学会与国家综合癌症网络指南均指出,年度乳腺X线摄影是唯一应执行的影像检查以发现局部复发,出现局部症状时可追加影像。
要点
- 无症状I期乳腺癌女性,初始分期检查排除转移无生存或生活质量获益。
- 年度乳腺X线摄影是唯一应执行的影像检查,用于发现无症状患者局部复发。
- 出现局部区域症状时,可追加其他影像检查。
核心结论
- 证据几乎不支持对无症状I期乳腺癌女性进行影像检查以排除转移。
- 无论是否接受初始转移灶检查,女性生存率或生活质量均无差异。
- 强化筛查与监测(含影像与实验室检查)与仅因症状或临床检查发现异常而检查相比,生存率无差异,生活质量相似。
研究设计与样本
- ACR适宜性标准为基于证据的指南,针对特定临床状况,由多学科专家小组每3年审查一次。
- 指南制定与审查包括对同行评议期刊当前医学文献的广泛分析,并采用改良Delphi共识方法对影像与治疗程序的适宜性进行评分。
- 证据不足或不确定时,可采用专家意见推荐影像或治疗。
诊断标准与关键数值
- 美国临床肿瘤学会与国家综合癌症网络指南指出,年度乳腺X线摄影是唯一应执行的影像检查,用于发现无症状患者的局部乳腺复发。
- 若患者有局部区域症状,可能需要追加影像检查。
临床应用与阅片要点
- 对无症状I期乳腺癌女性,初始分期检查不应常规用于排除转移。
- 年度乳腺X线摄影是唯一应执行的影像检查以检测局部复发。
- 患者出现局部区域症状时,可追加影像检查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Women newly diagnosed with stage 1 breast cancer have an early-stage disease that can be effectively treated. Evidence provides little justification for performing imaging to exclude metastasis in asymptomatic women with stage I breast cancer. No differences have been found in survival or quality of life in women regardless of whether they underwent initial workup for metastatic disease. These women generally prefer intensive follow-up to detect an early recurrence. However, survival rates do not differ between women who obtain intensive screening and surveillance, with imaging and laboratory studies, and women who undergo testing only as a result of development of symptoms or findings on clinical examinations. In addition, quality of life is similar for women who undergo intensive surveillance compared with those who do not. American Society of Clinical Oncology and National Comprehensive Cancer Network guidelines state that annual mammography is the only imaging examination that should be performed to detect a localized breast recurrence in asymptomatic patients. Additional imaging may be needed if the patient has locoregional symptoms. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review by the panel include extensive analysis of current medical literature from peer-reviewed journals and application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures. When evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.
引用
- Moy L, Newell MS, Mahoney MC, et al. ACR Appropriateness Criteria Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women. J Am Coll Radiol. 2016. PMID: 27814823. doi:10.1016/j.jacr.2016.09.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。